Main	O
Outcomes	O
and	O
Measures	O
Primary	O
outcome	O
was	O
time	B-PrimaryOutcome
to	I-PrimaryOutcome
clinical	I-PrimaryOutcome
improvement	I-PrimaryOutcome
within	B-TimeFrame
28	I-TimeFrame
days	I-TimeFrame
,	O
defined	O
as	O
patient	B-OutcomeDefinition
discharged	I-OutcomeDefinition
alive	I-OutcomeDefinition
or	I-OutcomeDefinition
reduction	I-OutcomeDefinition
of	I-OutcomeDefinition
2	I-OutcomeDefinition
points	I-OutcomeDefinition
on	I-OutcomeDefinition
a	I-OutcomeDefinition
6	I-OutcomeDefinition
-	I-OutcomeDefinition
point	I-OutcomeDefinition
disease	I-OutcomeDefinition
severity	I-OutcomeDefinition
scale	I-OutcomeDefinition
(	I-OutcomeDefinition
ranging	I-OutcomeDefinition
from	I-OutcomeDefinition
1	I-OutcomeDefinition
[	I-OutcomeDefinition
discharge	I-OutcomeDefinition
]	I-OutcomeDefinition
to	I-OutcomeDefinition
6	I-OutcomeDefinition
[	I-OutcomeDefinition
death	I-OutcomeDefinition
]	I-OutcomeDefinition
)	I-OutcomeDefinition
.	O

Secondary	O
outcomes	O
included	O
28	B-TimeFrame
-	I-TimeFrame
day	I-TimeFrame
mortality	B-SecondaryOutcome
,	O
time	B-SecondaryOutcome
to	I-SecondaryOutcome
discharge	I-SecondaryOutcome
,	O
and	O
the	O
rate	B-SecondaryOutcome
of	I-SecondaryOutcome
viral	I-SecondaryOutcome
polymerase	I-SecondaryOutcome
chain	I-SecondaryOutcome
reaction	I-SecondaryOutcome
(	I-SecondaryOutcome
PCR	I-SecondaryOutcome
)	I-SecondaryOutcome
results	I-SecondaryOutcome
turned	I-SecondaryOutcome
from	I-SecondaryOutcome
positive	I-SecondaryOutcome
at	I-SecondaryOutcome
baseline	I-SecondaryOutcome
to	I-SecondaryOutcome
negative	I-SecondaryOutcome
at	B-TimeFrame
up	I-TimeFrame
to	I-TimeFrame
72	I-TimeFrame
hours	I-TimeFrame
.	O

Outcome	O
Measures	O

The	O
primary	O
end	O
point	O
was	O
time	O
to	O
clinical	O
improvement	O
within	O
a	O
28	O
-	O
day	O
period	O
.	O

Clinical	O
improvement	O
was	O
defined	O
as	O
patient	O
discharge	O
or	O
a	O
reduction	O
of	O
2	O
points	O
on	O
a	O
6	O
-	O
point	O
disease	O
severity	O
scale	O
.	O
13	O
The	O
scale	O
was	O
defined	O
as	O
follows	O
:	O
6	O
points	O
,	O
death	O
;	O
5	O
points	O
,	O
hospitalization	O
plus	O
extracorporeal	O
membrane	O
oxygenation	O
(	O
ECMO	O
)	O
or	O
invasive	O
mechanical	O
ventilation	O
;	O
4	O
points	O
,	O
hospitalization	O
plus	O
noninvasive	O
ventilation	O
or	O
high	O
-	O
flow	O
supplemental	O
oxygen	O
;	O
3	O
points	O
,	O
hospitalization	O
plus	O
supplemental	O
oxygen	O
(	O
not	O
high	O
-	O
flow	O
or	O
noninvasive	O
ventilation	O
)	O
;	O
2	O
points	O
,	O
hospitalization	O
with	O
no	O
supplemental	O
oxygen	O
;	O
1	O
point	O
,	O
hospital	O
discharge	O
.	O

Patient	O
discharge	O
criteria	O
included	O
body	B-OutcomeDefinition
temperature	I-OutcomeDefinition
returned	I-OutcomeDefinition
to	I-OutcomeDefinition
normal	I-OutcomeDefinition
for	I-OutcomeDefinition
longer	I-OutcomeDefinition
than	I-OutcomeDefinition
3	I-OutcomeDefinition
days	I-OutcomeDefinition
,	I-OutcomeDefinition
respiratory	I-OutcomeDefinition
symptoms	I-OutcomeDefinition
significantly	I-OutcomeDefinition
improved	I-OutcomeDefinition
without	I-OutcomeDefinition
the	I-OutcomeDefinition
need	I-OutcomeDefinition
for	I-OutcomeDefinition
oxygen	I-OutcomeDefinition
support	I-OutcomeDefinition
,	I-OutcomeDefinition
and	I-OutcomeDefinition
2	I-OutcomeDefinition
consecutive	I-OutcomeDefinition
negative	I-OutcomeDefinition
PCR	I-OutcomeDefinition
test	I-OutcomeDefinition
results	I-OutcomeDefinition
from	I-OutcomeDefinition
nasopharyngeal	I-OutcomeDefinition
swabs	I-OutcomeDefinition
at	I-OutcomeDefinition
least	I-OutcomeDefinition
24	I-OutcomeDefinition
hours	I-OutcomeDefinition
apart	I-OutcomeDefinition
.	O

Secondary	O
clinical	O
outcomes	O
were	O
as	O
follows	O
:	O
(	O
1	O
)	O
28	B-TimeFrame
-	I-TimeFrame
day	I-TimeFrame
mortality	B-SecondaryOutcome
,	O
including	B-OutcomeDefinition
analysis	I-OutcomeDefinition
of	I-OutcomeDefinition
time	I-OutcomeDefinition
from	I-OutcomeDefinition
randomization	I-OutcomeDefinition
to	I-OutcomeDefinition
death	I-OutcomeDefinition
;	O
(	O
2	O
)	O
duration	B-SecondaryOutcome
of	I-SecondaryOutcome
hospitalization	I-SecondaryOutcome
,	O
including	B-OutcomeDefinition
analyses	I-OutcomeDefinition
of	I-OutcomeDefinition
time	I-OutcomeDefinition
from	I-OutcomeDefinition
randomization	I-OutcomeDefinition
to	I-OutcomeDefinition
discharge	I-OutcomeDefinition
,	I-OutcomeDefinition
time	I-OutcomeDefinition
from	I-OutcomeDefinition
admission	I-OutcomeDefinition
to	I-OutcomeDefinition
discharge	I-OutcomeDefinition
,	I-OutcomeDefinition
and	I-OutcomeDefinition
28	I-OutcomeDefinition
-	I-OutcomeDefinition
day	I-OutcomeDefinition
discharge	I-OutcomeDefinition
rates	I-OutcomeDefinition
;	O
and	O
(	O
3	O
)	O
conversion	B-SecondaryOutcome
of	I-SecondaryOutcome
nasopharyngeal	I-SecondaryOutcome
swab	I-SecondaryOutcome
viral	I-SecondaryOutcome
PCR	I-SecondaryOutcome
results	I-SecondaryOutcome
from	I-SecondaryOutcome
positive	I-SecondaryOutcome
at	I-SecondaryOutcome
baseline	I-SecondaryOutcome
to	I-SecondaryOutcome
negative	I-SecondaryOutcome
at	I-SecondaryOutcome
follow	I-SecondaryOutcome
-	I-SecondaryOutcome
up	I-SecondaryOutcome
assessed	O
at	B-TimeFrame
24	I-TimeFrame
,	I-TimeFrame
48	I-TimeFrame
,	I-TimeFrame
and	I-TimeFrame
72	I-TimeFrame
hours	I-TimeFrame
.	O

Once	O
nasopharyngeal	O
swab	O
viral	O
PCR	O
testing	O
yielded	O
negative	O
results	O
2	O
times	O
consecutively	O
,	O
no	O
further	O
testing	O
was	O
performed	O
.	O

A	O
post	O
hoc	O
analysis	O
was	O
added	O
to	O
compare	O
rates	B-OtherOutcome
of	I-OtherOutcome
improvement	I-OtherOutcome
at	B-TimeFrame
days	I-TimeFrame
7	I-TimeFrame
,	I-TimeFrame
14	I-TimeFrame
,	I-TimeFrame
and	I-TimeFrame
28	I-TimeFrame
.	O

This	O
clinical	O
trial	O
was	O
an	O
open	O
-	O
label	O
,	O
randomized	O
clinical	O
study	O
.	O

To	O
avoid	O
assessment	O
bias	O
,	O
the	O
evaluation	O
of	O
clinical	O
outcomes	O
was	O
performed	O
by	O
an	O
investigator	O
who	O
was	O
blind	O
to	O
the	O
study	O
group	O
allocation	O
.	O

